MorphoSys Expands Oncology Footprint with Constellation and Royalty Pharma

By Neha Madhwani & Michelle Liu

Pharma Deals Review: Vol 2021 Issue 6 (Table of Contents)

Published: 29 Jun-2021

DOI: 10.3833/pdr.v2021.i6.2618     ISSN: 1756-7874

Section: Mergers & Acquisitions



In its largest M&A deal to date, MorphoSys has agreed to acquire Constellation Pharmaceuticals to expand its oncology offerings...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details